Screening Reminders for Barrett's Esophagus
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to increase the frequency of screenings for Barrett's esophagus (BE), a condition that can raise the risk of esophageal cancer. Researchers seek to determine if screening reminders can encourage more people to get checked for BE during visits to doctors in a large healthcare system in New Jersey. Participants will either follow the usual care routine or receive additional screening reminders. Those with appointments with participating providers might be suitable for this study. As an unphased trial, this study offers a chance to contribute to research that could improve screening practices and potentially save lives.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this screening reminder is safe for optimizing screening practices?
Research has shown that using reminders for Barrett's esophagus screenings is generally safe. This study does not involve a new drug or medical procedure but focuses on reminding doctors and patients about regular screenings.
These reminders aim to increase the number of people getting screened, potentially leading to better health outcomes over time. Since the reminders involve communication, they pose no direct health risks.
Overall, this approach is very safe because it involves sending reminders rather than providing medical treatment. Studies have not reported any negative effects from using these screening reminders.12345Why are researchers excited about this trial?
Researchers are excited about the use of screening reminders for Barrett's Esophagus because these reminders could significantly improve patient compliance with regular screenings. Unlike the standard approach, which often relies on patients remembering their appointments, these reminders proactively prompt individuals to schedule and attend screenings. This method could lead to earlier detection of changes in the esophagus, potentially preventing the progression to more serious conditions like esophageal cancer. By enhancing follow-up rates, screening reminders aim to transform how effectively Barrett's Esophagus is monitored and managed.
What evidence suggests that screening reminders are effective for optimizing Barrett's Esophagus screening?
This trial will compare the effectiveness of screening reminders for Barrett's esophagus. Studies have shown that screening for Barrett's esophagus (BE) is crucial because it can detect esophageal cancer early, reducing the risk of death and illness. However, fewer than 35% of eligible individuals undergo screening. Research indicates that 71% of people are willing to be screened using any method. Many doctors, particularly specialists in the digestive system, understand the benefits but often fail to communicate them effectively to patients. Reminders for doctors to discuss screening with their patients could increase screening rates, leading to better detection and treatment for those at risk.12467
Who Is on the Research Team?
Arvind Trindade, MD
Principal Investigator
Professor of Medicine
Are You a Good Fit for This Trial?
This trial is for individuals who may be at risk of developing Barrett's Esophagus (BE), a condition that can lead to esophageal cancer. It aims to improve screening rates in a primary care setting within an academic healthcare system in NJ.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of screening reminders for eligible patients to increase BE screening rates
Follow-up
Participants are monitored for BE screening rates and outcomes compared to historical controls
What Are the Treatments Tested in This Trial?
Interventions
- Screening Reminder
Trial Overview
The study is testing whether using screening reminders can increase the number of patients getting screened for BE, compared to current practices without such reminders.
How Is the Trial Designed?
2
Treatment groups
Active Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
Citations
Screening for Barrett's Esophagus: Results from a ...
This survey suggests substantial interest in the community setting for BE/EAC screening, with 71 % of responders agreeing to be screened with any modality.
Survey Study on Barrett's Esophagus Screening
Study Overview. The goal of this study is to optimize Barrett's Esophagus (BE) screening to reduce the incidence, morbidity, and mortality of Esophageal ...
Understanding Compliance, Practice Patterns, and Barriers ...
More than two thirds of GIs but only 31.8% of PCPs discuss the benefits and harms of BE screening in detail with patients with chronic GERD.
Advances in Screening for Barrett's Esophagus and ...
In this review, we aim to provide a comprehensive review of recent innovations in the nonendoscopic detection of BE and EAC.
5.
journals.lww.com
journals.lww.com/ajg/fulltext/2024/09000/the_public_s_intended_uptake_of_hypothetical.18.aspxThe Public's Intended Uptake of Hypothetical Esophageal...
Screening for early esophageal adenocarcinoma (EAC) may potentially reduce EAC-related mortality and morbidity. This study aimed to examine the Dutch ...
Screening Reminders for Barrett's Esophagus
The purpose of this study is to examine current screening practices and determine if implementation of screening reminders can optimize screening practices for ...
Challenges and Strategies to Screening for Barrett's ...
Dr Kolb here talking to us about the challenges and strategies to screening for Barrett's esophagus and esophageal cancers.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.